Association of Levels of Interleukin 17 and T-helper 17 Count with Symptom Severity and Etiology of Chronic Heart Failure: a Case-control Study

Overview

Journal Croat Med J

Specialty General Medicine

Date 2018 Sep 12

PMID 30203627

Citations 9

Authors

Zahra Rahmati

Ali Akbar Amirzargar

Samaneh Saadati

Farzaneh Rahmani

Mohammad Jafar Mahmoudi

Zahra Rahnemoon

Vajiheh Eskandari

Fatemeh Gorzin

Mona Hedayat

Nima Rezaei

Affiliations

Soon will be listed here.

Abstract

Aim: To assess the association between the levels of interleukin 17 (IL-17) and T-helper 17 count and symptom severity and etiology of chronic heart failure.

Methods: This single-center prospective case-control study, conducted from December 1, 2015 to January 1, 2017 in Tehran Heart Center, evaluated gene expression of IL-17, relative count of (CD4+IL17+) Th17 cells and CD4+ helper T-cells in peripheral blood mononuclear cells of 42 patients with CHF and 42 matched controls. A multiple regression model assessed the predictors of peripheral IL-17 expression and Th17 count in patients with CHF.

Results: IL-17 expression was increased in patients with CHF, both at baseline and after stimulation. IL-17 and Th17 counts were higher in patients with advanced New York Heart Association (NYHA) functional class (class IV) than in controls and patients with class I. Th17 cell population expanded in patients with CHF, more prominently in patients with class IV than in controls and patients with class I, regardless of the ischemic or non-ischemic CHF origin. Multiple regression model showed that NYHA was the only meaningful predictor of IL-17 levels and Th17 count.

Conclusion: We demonstrated the lymphocytic origin of IL-17 production in advanced CHF and the ability of disease severity to predict IL-17 levels. Oxford Centre for Evidence-based Medicine level of evidence: 3.

Citing Articles

The role of circulating cytokines in heart failure: a bidirectional, two-sample Mendelian randomization study.

Zheng H, Mao X, Fu Z, Chen C, Lv J, Wang Y Front Cardiovasc Med. 2024; 11:1332015.

PMID: 39502198 PMC: 11534875. DOI: 10.3389/fcvm.2024.1332015.

The balance between CD4+ T helper 17 and T-cell immunoglobulin and mucin domain 3 is involved in the pathogenesis and development of atrial fibrillation.

Dai W, Zhang J, Wang Y, Zhou J, Dai Q, Lv J Afr Health Sci. 2024; 23(3):607-615.

PMID: 38357157 PMC: 10862566. DOI: 10.4314/ahs.v23i3.71.

Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction.

Hu Y, Chen X, Mei X, Luo Z, Wu H, Zhang H Open Med (Wars). 2023; 18(1):20230878.

PMID: 38152337 PMC: 10751901. DOI: 10.1515/med-2023-0878.

Immunomodulation and immunopharmacology in heart failure.

Markousis-Mavrogenis G, Baumhove L, Al-Mubarak A, Aboumsallem J, Bomer N, Voors A Nat Rev Cardiol. 2023; 21(2):119-149.

PMID: 37709934 DOI: 10.1038/s41569-023-00919-6.

The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies.

Cianci R, Franza L, Borriello R, Pagliari D, Gasbarrini A, Gambassi G Biomedicines. 2022; 10(11).

PMID: 36359233 PMC: 9687270. DOI: 10.3390/biomedicines10112712.

References

Chen Z, Yan W, Mao Y, Ni Y, Zhou L, Song H . Effect of Aerobic Exercise on Treg and Th17 of Rats with Ischemic Cardiomyopathy. J Cardiovasc Transl Res. 2018; 11(3):230-235. DOI: 10.1007/s12265-018-9794-0. View

Wu L, Ong S, Talor M, Barin J, Baldeviano G, Kass D . Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med. 2014; 211(7):1449-64. PMC: 4076595. DOI: 10.1084/jem.20132126. View

Charan J, Biswas T . How to calculate sample size for different study designs in medical research?. Indian J Psychol Med. 2013; 35(2):121-6. PMC: 3775042. DOI: 10.4103/0253-7176.116232. View

Gorzin F, Amirzargar A, Mahmoudi M, Rahnemoon Z, Najmi Varzaneh F, Hedayat M . FOXP3, RORγt and IL-10 cytokine profile in chronic heart failure. Bratisl Lek Listy. 2017; 118(10):637-641. DOI: 10.4149/BLL_2017_122. View

Zhang Q, Hu L, Yin C, Chen P, Li H, Sun X . Catechin ameliorates cardiac dysfunction in rats with chronic heart failure by regulating the balance between Th17 and Treg cells. Inflamm Res. 2014; 63(8):619-28. DOI: 10.1007/s00011-014-0734-4. View

Chang S, Hsiao Y, Tsai Y, Lin S, Liu S, Lin Y . Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure. J Mol Cell Cardiol. 2018; 122:69-79. DOI: 10.1016/j.yjmcc.2018.08.005. View

Zhu Z, Li J, Liu J, Tang T, Ding Y, Liao Y . Circulating Th17 cells are not elevated in patients with chronic heart failure. Scand Cardiovasc J. 2012; 46(5):295-300. DOI: 10.3109/14017431.2012.699096. View

Okamoto N, Noma T, Ishihara Y, Miyauchi Y, Takabatake W, Oomizu S . Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction. Int Heart J. 2014; 55(3):271-7. DOI: 10.1536/ihj.13-343. View

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

10.

Xie Y, Li M, Wang X, Zhang X, Peng T, Yang Y . In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy. PLoS One. 2013; 8(8):e72158. PMC: 3748008. DOI: 10.1371/journal.pone.0072158. View

11.

Feng W, Li W, Liu W, Wang F, Li Y, Yan W . IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp Mol Pathol. 2009; 87(3):212-8. DOI: 10.1016/j.yexmp.2009.06.001. View

12.

Yan X, Shichita T, Katsumata Y, Matsuhashi T, Ito H, Ito K . Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc. 2013; 1(5):e004408. PMC: 3541626. DOI: 10.1161/JAHA.112.004408. View

13.

Milovanovic M, Pesic G, Nikolic V, Jevtovic-Stoimenov T, Vasic K, Jovic Z . Vitamin D deficiency is associated with increased IL-17 and TNFα levels in patients with chronic heart failure. Arq Bras Cardiol. 2012; 98(3):259-65. DOI: 10.1590/s0066-782x2012005000019. View

14.

Liu Y, Zhu H, Su Z, Sun C, Yin J, Yuan H . IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. Int Immunol. 2012; 24(10):605-12. DOI: 10.1093/intimm/dxs056. View

15.

Khan S, Joyce J, Margulies K, Tsuda T . Enhanced bioactive myocardial transforming growth factor-β in advanced human heart failure. Circ J. 2014; 78(11):2711-8. DOI: 10.1253/circj.cj-14-0511. View

16.

Kirkpatrick J, Vannan M, Narula J, Lang R . Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007; 50(5):381-96. DOI: 10.1016/j.jacc.2007.03.048. View

17.

Bansal S, Ismahil M, Goel M, Patel B, Hamid T, Rokosh G . Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure. Circ Heart Fail. 2017; 10(3):e003688. PMC: 5331621. DOI: 10.1161/CIRCHEARTFAILURE.116.003688. View

18.

Yue Y, Meng K, Pu Y, Zhang X . Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017; 133:124-130. DOI: 10.1016/j.diabres.2017.08.018. View

19.

Zhou S, Yuan J, Liao M, Xia N, Tang T, Li J . IL-17A promotes ventricular remodeling after myocardial infarction. J Mol Med (Berl). 2014; 92(10):1105-16. DOI: 10.1007/s00109-014-1176-8. View

20.

Eskandari V, Amirzargar A, Mahmoudi M, Rahnemoon Z, Rahmani F, Sadati S . Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci. 2017; 187(2):359-368. DOI: 10.1007/s11845-017-1680-2. View